Matthias Weigel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Matthias Weigel has a total of 351 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Granziera
Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Switzerland
19 shared publications - Ludwig Kappos
University Hospital Basel, Switzerland
14 shared publications - Alessandro Cagol
Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Switzerland
13 shared publications - Po-Jui Lu
Multiple Sclerosis Centre, Departments of Neurology, Clinical Research and Biomedicine, University Hospital and University Basel, Basel, Switzerland
12 shared publications - Jens Kuhle
Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland; and
10 shared publications - Mario Ocampo-Pineda
University of Basel
9 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Oxford University Press (OUP) in Brain Communications
Cervical and thoracic spinal cord gray and white matter atrophy - a longitudinal study in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is characterized by progressive degeneration of upper and lower motor neurons. Spinal cord (SC) MRI metrics have been suggested as potential biomarkers in ALS, but longitudinal data elucidating the development of cervical and thoracic SC gray matter (GM) and white matter (WM) atrophy remain limited. Radially sampled Averaged Magnetization Inversion Recovery Acquisitions (rAMIRA) enables the investigation of SC substructures. The objective was to investigate longitudinal changes in cervical and thoracic SC MRI metrics in patients with ALS compared to healthy age- and sex-matched controls (HC) using rAMIRA imaging and to examine the relationship of these changes with clinical phenotype and functional decline. 41 patients with ALS and 41 age- and sex-matched HC underwent rAMIRA MRI at baseline and every six months for up to 24 months. Axial SC images were acquired at intervertebral disc levels C2/C3–C5/C6 and the thoracic enlargement (Tmax) level. SC total cross-sectional area (TCA), gray (GMA), and white matter areas (WMA) were segmented and analyzed using linear mixed-effects models to compare longitudinal changes between groups. Associations between longitudinal changes in SC metrics, clinical phenotype, and ALS Functional Rating Scale-Revised (ALSFRS-R) were examined. At baseline, patients with ALS exhibited significant TCA, GMA, and WMA reductions at cervical and thoracic levels compared to HC, except for WMA at Tmax. Over 24 months, significant longitudinal TCA and GMA decline was observed at multiple cervical and thoracic levels. WMA significantly declined only at level C3/C4. Stratification by disease onset revealed distinct patterns: patients with bulbar onset showed preserved cervical SC area metrics over 12 months, whereas those with cervical and lumbar onset exhibited marked TCA, GMA and WMA SC decline. Longitudinal TCA, GMA, and WMA reductions correlated with 12-month ALSFRS-R decline. These findings suggest that SC imaging metrics reflect the functional impact of ALS. rAMIRA imaging allows to detect significant cervical and thoracic SC atrophy in ALS over 12 and 24 months. SC TCA and GMA atrophy is most pronounced in areas corresponding to symptom onset and is linked to overall clinical disability. SC imaging, capturing both GM and WM changes, represents a promising tool for monitoring disease progression and may inform the multimodal development of future imaging markers in ALS. Future studies with larger cohorts and earlier disease stages are warranted to validate these findings.
- 10 November 2026
- Published by Oxford University Press (OUP) in Brain Communications
Open AccessCervical and thoracic spinal cord gray and white matter atrophy - a longitudinal study in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is characterized by progressive degeneration of upper and lower motor neurons. Spinal cord (SC) MRI metrics have been suggested as potential biomarkers in ALS, but longitudinal data elucidating the development of cervical and thoracic SC gray matter (GM) and white matter (WM) atrophy remain limited. Radially sampled Averaged Magnetization Inversion Recovery Acquisitions (rAMIRA) enables the investigation of SC substructures. The objective was to investigate longitudinal changes in cervical and thoracic SC MRI metrics in patients with ALS compared to healthy age- and sex-matched controls (HC) using rAMIRA imaging and to examine the relationship of these changes with clinical phenotype and functional decline. 41 patients with ALS and 41 age- and sex-matched HC underwent rAMIRA MRI at baseline and every six months for up to 24 months. Axial SC images were acquired at intervertebral disc levels C2/C3–C5/C6 and the thoracic enlargement (Tmax) level. SC total cross-sectional area (TCA), gray (GMA), and white matter areas (WMA) were segmented and analyzed using linear mixed-effects models to compare longitudinal changes between groups. Associations between longitudinal changes in SC metrics, clinical phenotype, and ALS Functional Rating Scale-Revised (ALSFRS-R) were examined. At baseline, patients with ALS exhibited significant TCA, GMA, and WMA reductions at cervical and thoracic levels compared to HC, except for WMA at Tmax. Over 24 months, significant longitudinal TCA and GMA decline was observed at multiple cervical and thoracic levels. WMA significantly declined only at level C3/C4. Stratification by disease onset revealed distinct patterns: patients with bulbar onset showed preserved cervical SC area metrics over 12 months, whereas those with cervical and lumbar onset exhibited marked TCA, GMA and WMA SC decline. Longitudinal TCA, GMA, and WMA reductions correlated with 12-month ALSFRS-R decline. These findings suggest that SC imaging metrics reflect the functional impact of ALS. rAMIRA imaging allows to detect significant cervical and thoracic SC atrophy in ALS over 12 and 24 months. SC TCA and GMA atrophy is most pronounced in areas corresponding to symptom onset and is linked to overall clinical disability. SC imaging, capturing both GM and WM changes, represents a promising tool for monitoring disease progression and may inform the multimodal development of future imaging markers in ALS. Future studies with larger cohorts and earlier disease stages are warranted to validate these findings.
- Open Access
- 30 October 2026
- Published by MIT Press in Network Neuroscience
- Vol. 10 (4) , 985-1006
Understanding cognitive impairment in multiple sclerosis using structural and functional network measures and classification algorithms
Cognitive impairment (CI) is common in multiple sclerosis (MS), yet the network-level mechanisms underlying CI remain poorly understood. This study aimed to clarify how the joint organization of structural and functional brain networks contributes to CI in MS, and how network-derived features change when clinical information and MRI-derived measures are added. We analyzed neuropsychological and multimodal MRI data from the Amsterdam MS cohort (N = 330) and assessed generalizability externally (N = 27). Graph-theoretical measures of brain connectivity were extracted from diffusion-weighted and resting-state functional MRI. Machine learning models classified cognitively impaired versus preserved patients. Classification performance was quantified using the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity. Feature importance was evaluated using Shapley values. Network-derived features improved discrimination over demographic information alone (AUROC = 0.77; p < 0.001). Adding MRI-derived measures significantly improved performance (AUROC = 0.81; p < 0.001), whereas clinical variables added little additional information (AUROC = 0.79; p = 0.65). External validation demonstrated good discriminative ability (AUROC = 0.76) but low sensitivity. Structural connectivity within the dorsal attention network emerged as an informative feature. These findings suggest that network-derived features help classify cognitive status in MS and remain relevant alongside conventional features. Structural connectivity, especially within the dorsal attention network, may provide insight into systems-level correlates of CI in MS.
- 30 October 2026
- Published by MIT Press in Network Neuroscience
- Vol. 10 (4) , 985-1006
Open AccessUnderstanding cognitive impairment in multiple sclerosis using structural and functional network measures and classification algorithms
Cognitive impairment (CI) is common in multiple sclerosis (MS), yet the network-level mechanisms underlying CI remain poorly understood. This study aimed to clarify how the joint organization of structural and functional brain networks contributes to CI in MS, and how network-derived features change when clinical information and MRI-derived measures are added. We analyzed neuropsychological and multimodal MRI data from the Amsterdam MS cohort (N = 330) and assessed generalizability externally (N = 27). Graph-theoretical measures of brain connectivity were extracted from diffusion-weighted and resting-state functional MRI. Machine learning models classified cognitively impaired versus preserved patients. Classification performance was quantified using the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity. Feature importance was evaluated using Shapley values. Network-derived features improved discrimination over demographic information alone (AUROC = 0.77; p < 0.001). Adding MRI-derived measures significantly improved performance (AUROC = 0.81; p < 0.001), whereas clinical variables added little additional information (AUROC = 0.79; p = 0.65). External validation demonstrated good discriminative ability (AUROC = 0.76) but low sensitivity. Structural connectivity within the dorsal attention network emerged as an informative feature. These findings suggest that network-derived features help classify cognitive status in MS and remain relevant alongside conventional features. Structural connectivity, especially within the dorsal attention network, may provide insight into systems-level correlates of CI in MS.
- Open Access
- 9 October 2026
- Published by SAGE Publications in Multiple Sclerosis Journal – Experimental, Translational and Clinical
- Vol. 12 (4)
Macro- and microstructural changes in the upper cervical spinal cord and their clinical correlates in multiple sclerosis
Background: Spinal cord (SC) damage is central to multiple sclerosis (MS) progression but remains difficult to quantify with conventional magnetic resonance imaging (MRI). Objectives: To characterize upper cervical SC pathology using quantitative MRI (qMRI) and assess longitudinal changes and predictors of clinical progression and fluid biomarker trajectories. Methods: We conducted a prospective study including people with MS (PwMS) and healthy controls (HCs). Participants underwent brain 3T-MRI, clinical assessments, and serum biomarker analyses at baseline and 2 years, with clinical follow-up to a median of 3.0 years. SC lesion burden, morphometry, quantitative T1 (qT1), and magnetization transfer saturation (MTsat) metrics were derived. Results: We enrolled 183 PwMS and 100 HCs at baseline, with follow-up for a subset. PwMS showed widespread SC macro/microstructural damage compared with HCs, with qT1 at C1-C4 and MTsat at C4 providing the highest discrimination (model-area under the curve = 0.81). Disability was most strongly associated with cross-sectional area at C1–C2, and qT1 at C1, C2, and C4 ( R 2 = 0.49). Baseline SC metrics predicted disability worsening and progression independent of relapse activity, with lower transverse diameters at C3–C4 as key predictors (model-HRs = 0.59–0.69), and worsening serum glial fibrillary acidic protein but not serum neurofilament light chain. Conclusion: Upper cervical SC morphometry and qMRI capture clinically relevant pathology and are linked to disease evolution, supporting their potential prognostic value in MS.
- 9 October 2026
- Published by SAGE Publications in Multiple Sclerosis Journal – Experimental, Translational and Clinical
- Vol. 12 (4)
Open AccessMacro- and microstructural changes in the upper cervical spinal cord and their clinical correlates in multiple sclerosis
Background: Spinal cord (SC) damage is central to multiple sclerosis (MS) progression but remains difficult to quantify with conventional magnetic resonance imaging (MRI). Objectives: To characterize upper cervical SC pathology using quantitative MRI (qMRI) and assess longitudinal changes and predictors of clinical progression and fluid biomarker trajectories. Methods: We conducted a prospective study including people with MS (PwMS) and healthy controls (HCs). Participants underwent brain 3T-MRI, clinical assessments, and serum biomarker analyses at baseline and 2 years, with clinical follow-up to a median of 3.0 years. SC lesion burden, morphometry, quantitative T1 (qT1), and magnetization transfer saturation (MTsat) metrics were derived. Results: We enrolled 183 PwMS and 100 HCs at baseline, with follow-up for a subset. PwMS showed widespread SC macro/microstructural damage compared with HCs, with qT1 at C1-C4 and MTsat at C4 providing the highest discrimination (model-area under the curve = 0.81). Disability was most strongly associated with cross-sectional area at C1–C2, and qT1 at C1, C2, and C4 ( R 2 = 0.49). Baseline SC metrics predicted disability worsening and progression independent of relapse activity, with lower transverse diameters at C3–C4 as key predictors (model-HRs = 0.59–0.69), and worsening serum glial fibrillary acidic protein but not serum neurofilament light chain. Conclusion: Upper cervical SC morphometry and qMRI capture clinically relevant pathology and are linked to disease evolution, supporting their potential prognostic value in MS.
- 21 July 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
Choroid plexus morphological and microstructural changes across inflammatory phenotypes in multiple sclerosis
Background: Growing evidence supports choroid plexus (CP) involvement in MS pathophysiology, but phase-specific associations according to recent inflammatory activity and longitudinal dynamics remain unclear. Objective: To characterize CP alterations in MS using volumetric and quantitative magnetic resonance imaging (MRI) and explore associations with neuroinflammation and neurodegeneration. Methods: We analyzed cross-sectional and 2-year longitudinal data from 101 patients with active relapsing MS (RMS), 83 with inactive progressive MS (PMS), and 100 controls, with MS groups stratified by inflammatory activity within the prior year. CP volume, quantitative T1, and magnetization transfer saturation (MTsat) were assessed alongside imaging, serum, and clinical measures, with validation in a second cohort (62 active/357 inactive MS). Results: CP volume was increased in both active RMS and inactive PMS and was associated with lower total and cortical brain volumes. Associations with brain microstructural damage were more pronounced in periventricular regions, compatible with a surface-in pattern. Similar associations were observed in controls, suggesting CP volume may reflect processes beyond MS-specific pathology, including physiological factors. Longitudinally, CP volume increased exclusively in active RMS, with faster expansion associated with thalamic atrophy. CP MTsat was associated with cortical and paramagnetic rim lesions in inactive PMS. Conclusion: CP enlargement is consistent across MS phases. Longitudinal expansion occurs in active inflammatory disease and is associated with neurodegenerative changes.
- 21 July 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
Choroid plexus morphological and microstructural changes across inflammatory phenotypes in multiple sclerosis
Background: Growing evidence supports choroid plexus (CP) involvement in MS pathophysiology, but phase-specific associations according to recent inflammatory activity and longitudinal dynamics remain unclear. Objective: To characterize CP alterations in MS using volumetric and quantitative magnetic resonance imaging (MRI) and explore associations with neuroinflammation and neurodegeneration. Methods: We analyzed cross-sectional and 2-year longitudinal data from 101 patients with active relapsing MS (RMS), 83 with inactive progressive MS (PMS), and 100 controls, with MS groups stratified by inflammatory activity within the prior year. CP volume, quantitative T1, and magnetization transfer saturation (MTsat) were assessed alongside imaging, serum, and clinical measures, with validation in a second cohort (62 active/357 inactive MS). Results: CP volume was increased in both active RMS and inactive PMS and was associated with lower total and cortical brain volumes. Associations with brain microstructural damage were more pronounced in periventricular regions, compatible with a surface-in pattern. Similar associations were observed in controls, suggesting CP volume may reflect processes beyond MS-specific pathology, including physiological factors. Longitudinally, CP volume increased exclusively in active RMS, with faster expansion associated with thalamic atrophy. CP MTsat was associated with cortical and paramagnetic rim lesions in inactive PMS. Conclusion: CP enlargement is consistent across MS phases. Longitudinal expansion occurs in active inflammatory disease and is associated with neurodegenerative changes.
- Open Access
- 17 July 2026
- Published by Elsevier in Neuroimage: Reports
- Vol. 6 (3) , 100385
Multi-compartment Myelin Streamline Decomposition reveals tract-specific and global brain network myelination in Multiple Sclerosis
- 17 July 2026
- Published by Elsevier in Neuroimage: Reports
- Vol. 6 (3) , 100385
Open AccessMulti-compartment Myelin Streamline Decomposition reveals tract-specific and global brain network myelination in Multiple Sclerosis
- Open Access
- 24 June 2026
- Published by Oxford University Press (OUP) in Brain Communications
Investigating the association between gray matter hypoperfusion and atrophy in multiple sclerosis using arterial spin labelling
The study of gray matter (GM) perfusion abnormalities in multiple sclerosis (MS) is gaining increasing interest, thanks to the recent developments in MRI techniques such as arterial spin labelling (ASL). Previous studies in small mixed cohorts have demonstrated reduced perfusion in different GM regions in patients with MS compared to controls, especially in the frontal/parietal lobes and deep GM. In this multi-centre study, we aimed to investigate the relationship between ASL-perfusion patterns and GM atrophy in a large cohort of MS patients. We hypothesized that GM hypoperfusion is a phenomenon not wholly associated with the presence of structural atrophy. Therefore, we have evaluated whether GM perfusion changes are directly explained by underlying atrophy or occur in the absence of detectable GM tissue loss. Moreover, the relationship between clinical (physical and cognitive) measures and global GM perfusion level was assessed. Conventional structural and pseudo-continuous ASL data were acquired using 3T MRI scanners and a standardized protocol in four European MS centres.. We included in the analysis 170 subjects (96 relapsing-remitting MS [RRMS], 41 primary-progressive MS [PPMS] and 33 healthy controls [HC]) that exhibited acceptable data quality and compatible acquisition schemes/ASL maps. Global and regional cerebral blood flow (CBF) patterns were explored to identify group differences, statistically controlling for “morphometric covariates” (i.e., total brain volume, cortical thickness or subcortical volume) along with age, sex, disease duration and total T2-lesion load in the analysis of covariance (“basic covariates”). Similarly, partial correlation analyses were performed to assess the association of global CBF with physical (Expanded Disability Status Scale) and cognitive (Symbol Digit Modalities Test) scores. Global GM CBF values were lower in RRMS (64.1+20.9 ml/100g/min) and PPMS (52.9+16.1 ml/100g/min) compared to HC (78.5+21.1 ml/100g/min), with significant differences for both MS types compared to controls using both sets of covariates (pBonf≤0.05). Moreover, regional perfusion reduction encompassing several cortical and subcortical GM regions were found in patients versus controls, even after the inclusion of the morphometric covariates, while there were no differences in GM perfusion levels between MS phenotypes. In all patients considered together, no significant associations between global GM CBF and physical disability/cognitive tests scores were found when controlling for the confounding factors. These findings suggest that GM hypoperfusion is at least partially dissociated with atrophy. In this scenario, ASL-based perfusion may be a promising functional paraclinical tool to quantify GM neurovascular impairment in MS, aiding the understanding of the pathological mechanisms.
- 24 June 2026
- Published by Oxford University Press (OUP) in Brain Communications
Open AccessInvestigating the association between gray matter hypoperfusion and atrophy in multiple sclerosis using arterial spin labelling
The study of gray matter (GM) perfusion abnormalities in multiple sclerosis (MS) is gaining increasing interest, thanks to the recent developments in MRI techniques such as arterial spin labelling (ASL). Previous studies in small mixed cohorts have demonstrated reduced perfusion in different GM regions in patients with MS compared to controls, especially in the frontal/parietal lobes and deep GM. In this multi-centre study, we aimed to investigate the relationship between ASL-perfusion patterns and GM atrophy in a large cohort of MS patients. We hypothesized that GM hypoperfusion is a phenomenon not wholly associated with the presence of structural atrophy. Therefore, we have evaluated whether GM perfusion changes are directly explained by underlying atrophy or occur in the absence of detectable GM tissue loss. Moreover, the relationship between clinical (physical and cognitive) measures and global GM perfusion level was assessed. Conventional structural and pseudo-continuous ASL data were acquired using 3T MRI scanners and a standardized protocol in four European MS centres.. We included in the analysis 170 subjects (96 relapsing-remitting MS [RRMS], 41 primary-progressive MS [PPMS] and 33 healthy controls [HC]) that exhibited acceptable data quality and compatible acquisition schemes/ASL maps. Global and regional cerebral blood flow (CBF) patterns were explored to identify group differences, statistically controlling for “morphometric covariates” (i.e., total brain volume, cortical thickness or subcortical volume) along with age, sex, disease duration and total T2-lesion load in the analysis of covariance (“basic covariates”). Similarly, partial correlation analyses were performed to assess the association of global CBF with physical (Expanded Disability Status Scale) and cognitive (Symbol Digit Modalities Test) scores. Global GM CBF values were lower in RRMS (64.1+20.9 ml/100g/min) and PPMS (52.9+16.1 ml/100g/min) compared to HC (78.5+21.1 ml/100g/min), with significant differences for both MS types compared to controls using both sets of covariates (pBonf≤0.05). Moreover, regional perfusion reduction encompassing several cortical and subcortical GM regions were found in patients versus controls, even after the inclusion of the morphometric covariates, while there were no differences in GM perfusion levels between MS phenotypes. In all patients considered together, no significant associations between global GM CBF and physical disability/cognitive tests scores were found when controlling for the confounding factors. These findings suggest that GM hypoperfusion is at least partially dissociated with atrophy. In this scenario, ASL-based perfusion may be a promising functional paraclinical tool to quantify GM neurovascular impairment in MS, aiding the understanding of the pathological mechanisms.
- 6 March 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 32 (6) , 624-633
A multi-modal deep learning network for the classification of paramagnetic rim and remyelinated lesions in multiple sclerosis
Objectives: Robust automated classification of paramagnetic rim lesions (PRLs) and remyelinated lesions based on iron and myelin content in people with multiple sclerosis (pwMS). Materials and Methods: In this prospective study (2018–2022), three-dimensional (3D) brain magnetic resonance imaging (MRI) from 180 pwMS (mean age: 47 ± 14 years, 108 females) were acquired at 3T including fluid-attenuated inversion recovery, magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE), and T2*-weighted segmented echo-planar imaging. Post-processed quantitative susceptibility mapping (QSM) and filtered phase unwrapped (PU) images were generated. Ground truth was established through expert manual rating. Performance was assessed using nested cross-validation (CV) including outer test sets. Three neural network configurations were evaluated: (1) PRL classification with QSM and MP2RAGE, (2) PRL classification with PU and MP2RAGE, and (3) multiple lesion phenotype (MLP) classification with QSM and MP2RAGE. Results: For PRL classification, our network achieves a top mean validation F1 score of 0.737 ± 0.027 in the MP2RAGE-QSM configuration trained on PRLs, and a best test performance of 0.709 ± 0.040 when trained on MLP. The MP2RAGE-PU configuration yielded validation and test F1 scores of 0.733 ± 0.021 and 0.662 ± 0.037, respectively. The QSM-based MLP classification achieved a macro F1 test score of 0.728 ± 0.012. Conclusion: Deep learning can automate the classification of PRLs and QSM lesion phenotypes with high accuracy, potentially facilitating the detection of PRLs (included in the new diagnostic criteria) and remyelinated lesions, guiding personalized treatment decisions in pwMS.
- 6 March 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 32 (6) , 624-633
A multi-modal deep learning network for the classification of paramagnetic rim and remyelinated lesions in multiple sclerosis
Objectives: Robust automated classification of paramagnetic rim lesions (PRLs) and remyelinated lesions based on iron and myelin content in people with multiple sclerosis (pwMS). Materials and Methods: In this prospective study (2018–2022), three-dimensional (3D) brain magnetic resonance imaging (MRI) from 180 pwMS (mean age: 47 ± 14 years, 108 females) were acquired at 3T including fluid-attenuated inversion recovery, magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE), and T2*-weighted segmented echo-planar imaging. Post-processed quantitative susceptibility mapping (QSM) and filtered phase unwrapped (PU) images were generated. Ground truth was established through expert manual rating. Performance was assessed using nested cross-validation (CV) including outer test sets. Three neural network configurations were evaluated: (1) PRL classification with QSM and MP2RAGE, (2) PRL classification with PU and MP2RAGE, and (3) multiple lesion phenotype (MLP) classification with QSM and MP2RAGE. Results: For PRL classification, our network achieves a top mean validation F1 score of 0.737 ± 0.027 in the MP2RAGE-QSM configuration trained on PRLs, and a best test performance of 0.709 ± 0.040 when trained on MLP. The MP2RAGE-PU configuration yielded validation and test F1 scores of 0.733 ± 0.021 and 0.662 ± 0.037, respectively. The QSM-based MLP classification achieved a macro F1 test score of 0.728 ± 0.012. Conclusion: Deep learning can automate the classification of PRLs and QSM lesion phenotypes with high accuracy, potentially facilitating the detection of PRLs (included in the new diagnostic criteria) and remyelinated lesions, guiding personalized treatment decisions in pwMS.
- Open Access
- 23 February 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 32 (3) , 289-301
Clinical and MRI substrates of Symbol Digit Modalities Test impairment in multiple sclerosis patients with an adult- and late-onset
Background: Multiple sclerosis (MS) onset occurs at diverse ages. Age of onset impact on clinical, brain MRI, and cognitive profiles remains unclear. We investigated the substrates of Symbol Digit Modalities Test (SDMT) impairment in patients with late-onset MS (LOMS) (⩾45 years) compared to adult-onset MS (AOMS) (p = 0.751). LOMS showed higher LV (FDR- p = 0.018), gray matter (GM) atrophy (FDR- p = 0.050), intra- and inter-hemispheric disconnection compared to AOMS (all FDR- p < 0.028). Furthermore, LOMS showed higher modularity (FDR- p = 0.018) and decreased density (FDR- p < 0.001). Substrates of SDMT impairment were intra-hemispheric disconnection, LV, clustering coefficient, mean strength and efficiency (AUC = 0.730) in AOMS and commissural ratio and GM atrophy (AUC = 0.760) in LOMS. Conclusions: Substrates contributing to SDMT impairment differ between these two distinct cohorts, being primarily driven by network dysfunction in AOMS and neurodegenerative processes in LOMS.
- 23 February 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 32 (3) , 289-301
Open AccessClinical and MRI substrates of Symbol Digit Modalities Test impairment in multiple sclerosis patients with an adult- and late-onset
Background: Multiple sclerosis (MS) onset occurs at diverse ages. Age of onset impact on clinical, brain MRI, and cognitive profiles remains unclear. We investigated the substrates of Symbol Digit Modalities Test (SDMT) impairment in patients with late-onset MS (LOMS) (⩾45 years) compared to adult-onset MS (AOMS) (p = 0.751). LOMS showed higher LV (FDR- p = 0.018), gray matter (GM) atrophy (FDR- p = 0.050), intra- and inter-hemispheric disconnection compared to AOMS (all FDR- p < 0.028). Furthermore, LOMS showed higher modularity (FDR- p = 0.018) and decreased density (FDR- p < 0.001). Substrates of SDMT impairment were intra-hemispheric disconnection, LV, clustering coefficient, mean strength and efficiency (AUC = 0.730) in AOMS and commissural ratio and GM atrophy (AUC = 0.760) in LOMS. Conclusions: Substrates contributing to SDMT impairment differ between these two distinct cohorts, being primarily driven by network dysfunction in AOMS and neurodegenerative processes in LOMS.
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (5) , e200459
Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis
In multiple sclerosis (MS), neurodegeneration results from the interplay between disease-specific pathology and normal aging. Conventional MRI captures morphologic changes in neurodegeneration, while quantitative MRI (qMRI) provides biophysical measures of microstructural alterations. Combining these modalities may reveal how aging and pathology interact and contribute to disability progression in people with MS. We analyzed cross-sectional and longitudinal morphometry data from 1,353 patients with MS and 3,462 healthy controls (HCs). In addition, cross-sectional qMRI data, available for 378 HCs and 169 patients with MS, were analyzed separately. Morphometric measures and quantitative metrics were used to estimate brain-predicted age differences (brain-PADs) with machine learning. We assessed the added value of quantitative metrics over a model based exclusively on morphometric measures in brain age prediction. We also investigated the associations of brain-PADs derived from conventional and qMRI-based predictive models with clinical disability, serum inflammatory biomarkers of neuroaxonal and astrocytic injury, and lesion burden. Models combining morphometry and qMRI data achieved the best performance (mean absolute error: 5.73), outperforming those based on qMRI (6.62) or morphometry alone (8.00). Cross-sectional and longitudinal morphometry-based brain-PAD correlated with clinical disability, serum neurofilament light chain, and serum glial fibrillary acidic protein levels (all p < 0.01), with significant longitudinal interactions with time (all p < 0.05). Cross-sectional qMRI-based brain-PAD correlated with white matter lesion count (p = 0.042, R2 = 0.028) and paramagnetic rim lesion volume (p = 0.028, R2 = 0.020). Integrating qMRI improves brain age predictions. Brain-PAD serves as an imaging biomarker to quantify MS-associated aging and track disability and neuroinflammation progression.
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (5) , e200459
Open AccessUnraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis
In multiple sclerosis (MS), neurodegeneration results from the interplay between disease-specific pathology and normal aging. Conventional MRI captures morphologic changes in neurodegeneration, while quantitative MRI (qMRI) provides biophysical measures of microstructural alterations. Combining these modalities may reveal how aging and pathology interact and contribute to disability progression in people with MS. We analyzed cross-sectional and longitudinal morphometry data from 1,353 patients with MS and 3,462 healthy controls (HCs). In addition, cross-sectional qMRI data, available for 378 HCs and 169 patients with MS, were analyzed separately. Morphometric measures and quantitative metrics were used to estimate brain-predicted age differences (brain-PADs) with machine learning. We assessed the added value of quantitative metrics over a model based exclusively on morphometric measures in brain age prediction. We also investigated the associations of brain-PADs derived from conventional and qMRI-based predictive models with clinical disability, serum inflammatory biomarkers of neuroaxonal and astrocytic injury, and lesion burden. Models combining morphometry and qMRI data achieved the best performance (mean absolute error: 5.73), outperforming those based on qMRI (6.62) or morphometry alone (8.00). Cross-sectional and longitudinal morphometry-based brain-PAD correlated with clinical disability, serum neurofilament light chain, and serum glial fibrillary acidic protein levels (all p < 0.01), with significant longitudinal interactions with time (all p < 0.05). Cross-sectional qMRI-based brain-PAD correlated with white matter lesion count (p = 0.042, R2 = 0.028) and paramagnetic rim lesion volume (p = 0.028, R2 = 0.020). Integrating qMRI improves brain age predictions. Brain-PAD serves as an imaging biomarker to quantify MS-associated aging and track disability and neuroinflammation progression.
- Open Access
- 1 May 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (3) , e200388
White Matter Tract Degeneration in Multiple Sclerosis Patients With Progression Independent of Relapse Activity
Progression independent of relapse activity (PIRA) is associated with worse outcomes in people with multiple sclerosis (pwMS). Although previous research has linked PIRA to accelerated brain and spinal cord atrophy and compartmentalized chronic inflammation, the role of white matter (WM) tract degeneration remains unclear. This study aimed to explore the relationship between PIRA and the integrity of major WM tracts using diffusion tensor imaging (DTI). A cohort of 258 pwMS was stratified based on the presence or absence of PIRA over a 4-year follow-up period. At the end of follow-up, DTI metrics were compared between groups using propensity score-weighted linear regression models to account for potential confounders. PwMS with ≥1 PIRA event (n = 39) exhibited significant reductions in fractional anisotropy and increases in radial, axial, and mean diffusivity within the corpus callosum and motor tracts (false discovery rate-adjusted p ≤ 0.04) compared with those without PIRA, indicating more pronounced WM damage. Our findings highlight an association between PIRA and microstructural damage in key WM tracts. The observed DTI changes likely reflect processes such as Wallerian degeneration and contribute to the growing evidence linking PIRA to neurodegeneration.
- 1 May 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (3) , e200388
Open AccessWhite Matter Tract Degeneration in Multiple Sclerosis Patients With Progression Independent of Relapse Activity
Progression independent of relapse activity (PIRA) is associated with worse outcomes in people with multiple sclerosis (pwMS). Although previous research has linked PIRA to accelerated brain and spinal cord atrophy and compartmentalized chronic inflammation, the role of white matter (WM) tract degeneration remains unclear. This study aimed to explore the relationship between PIRA and the integrity of major WM tracts using diffusion tensor imaging (DTI). A cohort of 258 pwMS was stratified based on the presence or absence of PIRA over a 4-year follow-up period. At the end of follow-up, DTI metrics were compared between groups using propensity score-weighted linear regression models to account for potential confounders. PwMS with ≥1 PIRA event (n = 39) exhibited significant reductions in fractional anisotropy and increases in radial, axial, and mean diffusivity within the corpus callosum and motor tracts (false discovery rate-adjusted p ≤ 0.04) compared with those without PIRA, indicating more pronounced WM damage. Our findings highlight an association between PIRA and microstructural damage in key WM tracts. The observed DTI changes likely reflect processes such as Wallerian degeneration and contribute to the growing evidence linking PIRA to neurodegeneration.